The Uromigos
Un pódcast de The Uromigos
401 Episodo
-
Episode 343: ESMO 2024 - TiNivo-2 Trial
Publicado: 14/9/2024 -
Episode 342: ESMO 2024 Preview with Silke Gillessen
Publicado: 3/9/2024 -
Episode 341: Hormone Resistance in Prostate Cancer
Publicado: 27/8/2024 -
Episode 340: Cancer Immunity Cycle Update
Publicado: 19/8/2024 -
Episode 339: Tres Uramigas analizan lineamientos de ESMO para GU
Publicado: 9/8/2024 -
Episode 338: RCC: Debulking Nephrectomy, Adjuvant Therapy Future and More
Publicado: 6/8/2024 -
Episode 337: Updated NCCN Guidelines in RCC
Publicado: 30/7/2024 -
Episode 336: Which patients are not suitable for 1st line EVP in bladder cancer
Publicado: 24/7/2024 -
Episode 335: Novel immune therapies for renal cancer
Publicado: 19/7/2024 -
Episodio 334 en español: Tres Uramigas ASCO 2024
Publicado: 11/7/2024 -
Episode 333: The Uromigos Cup - The Netherlands
Publicado: 5/7/2024 -
Episode 332: The Uromigos Cup - Germany's Entry
Publicado: 26/6/2024 -
Episode 331: AUA 2024 NMIBC Highlights
Publicado: 21/6/2024 -
Episode 330: ASCO 2024 Highlights
Publicado: 10/6/2024 -
Episode 329: Japan in the Uromigos Cup qualifying round
Publicado: 7/6/2024 -
Episode 328 ASCO24: Emergency podcast - what the NADINA trial means for preoperative GU cancer studies
Publicado: 5/6/2024 -
Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates
Publicado: 4/6/2024 -
Episode 326 ASCO24: KIM-1 in Renal Cancer
Publicado: 3/6/2024 -
Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer
Publicado: 3/6/2024 -
Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC
Publicado: 2/6/2024
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
